PT - JOURNAL ARTICLE ED - , TI - â–¼Paclitaxel for ovarian cancer AID - 10.1136/dtb.1994.32641 DP - 1994 Jun 01 TA - Drug and Therapeutics Bulletin PG - 41--42 VI - 32 IP - 6 4099 - http://dtb.bmj.com/content/32/6/41.short 4100 - http://dtb.bmj.com/content/32/6/41.full SO - Drug Ther Bull1994 Jun 01; 32 AB - Relevant BNF section: 8.1.5Paclitaxel (Taxol - Bristol-Myers Squibb) is the first of a new group of cytotoxic drugs, the taxanes. It is licensed for the treatment of patients with metastatic ovarian carcinoma "where standard, platinum-containing, therapy has failed". What is its place in treatment?